Telemedicine predicts cognitive outcomes in anti-leucine-rich, glioma-inactivated 1 encephalitis

Takeaway

  • Telemedicine can accurately assess cognitive performance and functional status in people with anti-leucine-rich glioma-inactivated 1 (anti-LGI1) encephalitis.

Why this matters

  • People with anti-LGI1 encephalitis develop memory impairment, cognitive decline and behavioral changes which need to be comprehensively evaluated in the long-term.

  • Telemedicine via a structured telephone interview is feasible and provides an accurate tool for assessment of long-term outcomes of people with anti-LGI1 encephalitis.